Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 21

Citing Papers

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 Standout
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
2022 Standout
3 intermediate papers

Works of Lois La Grenade being referenced

Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)
2009
Risk factors for statin‐associated rhabdomyolysis
2006

Author Peers

Author Last Decade Papers Cites
Lois La Grenade 128 448 76 270 250 20 903
Carolyn Y. Neuland 15 331 12 30 24 17 1.0k
Yoshiaki Osawa 18 152 16 78 51 21 852
Tammy Smith 34 531 55 24 9 26 1.1k
Ruthann M. Giusti 19 105 19 37 30 19 990
Shinji Sunaga 25 489 35 19 12 16 889
Masanori Higuchi 58 394 7 14 13 24 742
Nathalie Fouchard 714 82 310 36 32 15 1.1k
Jemma Mayall 18 463 13 28 7 13 969
Kiyomi Kimura 31 115 31 353 6 44 951
Grant C. Hughes 38 531 33 22 3 24 1.0k

All Works

Loading papers...

Rankless by CCL
2026